Enterol

Medicinal product

(Invented) name

Enterol

Active substance (s)

Liofilizuotos Saccharomyces boulardii CNCM I-745 ląstelės

Strength

250 mg

Pharmaceutical form

milteliai geriamajai suspensijai

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A07FA02, Saccharomyces boulardii

Marketing authorisation holder

Biocodex, Prancūzija

Date of authorisation

2004-04-27

Date of renewal

2013-02-13

Documents

0011 Enterol milt geriam tirp_kaps RPP 2024 07 01.docx

0011 Pakuotės lapelis 2024 07 01.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Paketėlyje yra	1 vnt.
Liofilizuotos Saccharomyces boulardii CNCM I-745 ląstelės	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
11643	16093	1016093	paketėlis	N10		Nereceptinis	LT/1/04/0011/001	Tiekiama	-	-	No	-	-	Download
29251	31752	1031752	paketėlis	N20		Nereceptinis	LT/1/04/0011/003	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2013-02-13	Perregistruotas
2004-04-27	Registruotas